Huadong Medicine Co., Ltd (SHE:000963)
China flag China · Delayed Price · Currency is CNY
38.85
+1.44 (3.85%)
Apr 30, 2025, 3:04 PM CST

Huadong Medicine Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Net Income
3,5643,5122,8392,4992,3022,820
Upgrade
Depreciation & Amortization
840.83840.83809.56705.55591.56431
Upgrade
Other Amortization
23.9323.939.696.655.968.54
Upgrade
Loss (Gain) From Sale of Assets
5.465.46-4.32-8.260.03-322.64
Upgrade
Asset Writedown & Restructuring Costs
25.1925.195.14-22.68.022.51
Upgrade
Loss (Gain) From Sale of Investments
82.882.8202.15115.6252.917.93
Upgrade
Provision & Write-off of Bad Debts
112.18112.1825.7668.6941.6922.83
Upgrade
Other Operating Activities
-313.3387.18121.32137.61132.51179.92
Upgrade
Change in Accounts Receivable
-1,980-1,980-968.97-2,095-775.57-530.3
Upgrade
Change in Inventory
-498.85-498.85213.85-491.5218.09-37.73
Upgrade
Change in Accounts Payable
1,5661,566685.551,450770.58797.16
Upgrade
Change in Other Net Operating Assets
20.9820.9843.017.24-4.9
Upgrade
Operating Cash Flow
3,4013,7493,9292,3823,1703,411
Upgrade
Operating Cash Flow Growth
-7.86%-4.59%64.96%-24.86%-7.08%70.43%
Upgrade
Capital Expenditures
-1,893-1,728-1,607-1,193-819.1-1,473
Upgrade
Sale of Property, Plant & Equipment
27.1819.7610.8515.4379.16373.81
Upgrade
Cash Acquisitions
-603.23-620.24-134.06-415.09-819.6-
Upgrade
Divestitures
-----113.37-
Upgrade
Investment in Securities
116.08112.84-115.24-948.91-357.5-629.8
Upgrade
Other Investing Activities
244.1445.2394.52106.243.72-9.66
Upgrade
Investing Cash Flow
-2,109-2,170-1,751-2,436-1,987-1,739
Upgrade
Long-Term Debt Issued
-5,2514,8764,9752,2592,211
Upgrade
Total Debt Issued
5,0305,2514,8764,9752,2592,211
Upgrade
Long-Term Debt Repaid
--4,263-5,729-4,653-2,405-2,278
Upgrade
Total Debt Repaid
-4,340-4,263-5,729-4,653-2,405-2,278
Upgrade
Net Debt Issued (Repaid)
690.37987.92-852.43322.13-146.03-67.22
Upgrade
Issuance of Common Stock
--10.63104.65--
Upgrade
Repurchase of Common Stock
-4.13-4.13----
Upgrade
Common Dividends Paid
-1,683-1,702-594.21-576.49-460.11-565.73
Upgrade
Other Financing Activities
89.09-31.2842.6650.01-161.31-92.78
Upgrade
Financing Cash Flow
-908-749.66-1,393-99.71-767.45-725.73
Upgrade
Foreign Exchange Rate Adjustments
-67.51-475.95-9.777.11-21.44
Upgrade
Net Cash Flow
316.48781.99791.25-163.23422.73925.64
Upgrade
Free Cash Flow
1,5082,0212,3231,1892,3511,938
Upgrade
Free Cash Flow Growth
-24.99%-12.98%95.40%-49.44%21.26%199.03%
Upgrade
Free Cash Flow Margin
3.57%4.82%5.72%3.15%6.80%5.75%
Upgrade
Free Cash Flow Per Share
0.861.151.330.681.341.11
Upgrade
Cash Interest Paid
---0.620.95-
Upgrade
Cash Income Tax Paid
2,6302,5632,5523,0181,5392,165
Upgrade
Levered Free Cash Flow
517.831,2341,862604.482,1041,160
Upgrade
Unlevered Free Cash Flow
580.221,2941,934679.512,1471,203
Upgrade
Change in Net Working Capital
1,093534.79-477.31811.18-614.8-340.75
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.